Companies by Sector - Pharmaceuticals and Biotechnology
| EPIC | Company | Index | Dividend Yield | Market Cap | Price Close | % Change |
|---|---|---|---|---|---|---|
| AZN | AstraZeneca | FTSE 100 | 1.83 | £195.65B | 12,980.00 | 2.90% |
| GSK | GSK | FTSE 100 | 3.97 | £75.57B | 1,814.00 | 2.46% |
| HLN | Haleon | FTSE 100 | 2.30 | £32.78B | 382.70 | 2.71% |
| HIK | Hikma Pharmaceuticals | FTSE 250 | 3.60 | £3.49B | 1,694.00 | 1.32% |
| HCM | Hutchmed China | AIM | £1.76B | 202.00 | 4.80% | |
| INDV | Indivior | FTSE 250 | £1.54B | 1,238.00 | -3.10% | |
| GNS | Genus | FTSE 250 | 1.54 | £1.47B | 2,240.00 | -0.18% |
| OXB | Oxford BioMedica | FTSE Small Cap | £637.93M | 511.00 | -3.04% | |
| AVCT | Avacta Group | AIM | £296.94M | 61.00 | -7.00% | |
| PRTC | Puretech Health | FTSE Small Cap | £280.49M | 115.80 | 1.22% | |
| AGY | Allergy Therapeutics | AIM | £239.05M | 3.77 | -2.50% | |
| ANCR | Animalcare Group | AIM | 0.66 | £231.3M | 335.00 | -2.60% |
| BTG | BTG | AIM | 4.12 | £180.07M | 111.59 | -0.10% |
| DXRX | Diaceutics | AIM | £173M | 203.80 | -0.50% | |
| MXCT | Maxcyte Inc | AIM | £161.75M | 147.69 | -1.20% | |
| BMK | Benchmark Holdings | AIM | £135.69M | 22.05 | 1.50% | |
| SCLP | Scancell Holdings | AIM | £107.76M | 88.89 | -1.10% | |
| ANP | Anpario | AIM | 2.33 | £107.61M | 537.00 | -0.90% |
| BVXP | Bioventix | AIM | 7.41 | £105.8M | 2,025.00 | -2.20% |
| 4BB | 4basebio | AIM | £87.02M | 560.00 | -0.40% | |
| EAH | Eco Animal Health Group | AIM | £65.14M | 96.14 | -4.30% | |
| FARN | Faron Pharmaceuticals OY | AIM | £65.06M | 33.00 | 1.10% | |
| STX | Shield Therapeutics | AIM | £57.99M | 5.42 | -7.90% | |
| OBI | Ondine Biomedical Inc | AIM | £54.3M | 9.68 | 2.60% | |
| POLB | Poolbeg Pharma | AIM | £49.94M | 6.54 | -2.10% | |
| ANIC | Agronomics | AIM | £46.7M | 4.31 | -0.60% | |
| HVO | Hvivo | AIM | £40.4M | 5.88 | -5.10% | |
| ABDX | Abingdon Health | AIM | £36.98M | 8.50 | 2.60% | |
| AREC | Arecor Therapeutics | AIM | £36.92M | 81.50 | -1.30% | |
| IXI | Ixico | AIM | £26.15M | 11.94 | -1.50% | |
| IMM | ImmuPharma | AIM | £24.39M | 3.90 | -3.00% | |
| EDEN | Eden Research | AIM | £24.1M | 3.00 | -2.40% | |
| SAR | Sareum Holdings | AIM | £21.64M | 15.49 | -5.60% | |
| GDR | Genedrive | AIM | £16.06M | 1.00 | -1.60% | |
| OBD | Oxford BioDynamics | AIM | £14.18M | 0.10 | -4.00% | |
| SBTX | SkinBioTherapeutics | AIM | £14M | 5.40 | -14.90% | |
| CEL | Celadon Pharmaceuticals | AIM | £9.23M | 13.40 | % | |
| VRCI | Verici Dx | AIM | £8.34M | 0.21 | -4.80% | |
| AGL | Angle | AIM | £7.72M | 2.40 | -0.70% | |
| OPTI | OptiBiotix Health | AIM | £5.99M | 5.80 | -3.30% | |
| PRM | Proteome Sciences | AIM | £5.59M | 1.59 | 8.00% | |
| TRX | Tissue Regenix Group | AIM | £5.16M | 7.25 | -1.50% | |
| FUM | Futura Medical | AIM | £2.8M | 0.18 | 14.60% | |
| VAL | ValiRx | AIM | £2.24M | 0.17 | -2.20% | |
| GUN | Gunsynd | AIM | – | 0.80 | 9.50% |